omeprazole has been researched along with acenocoumarol in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
Beysens, AJ; de Hoon, JN; Thijssen, HH; Van Bortel, LM | 1 |
De Vlaam-Schluter, GM; Snel, P; Trienekens, PH; Tytgat, GN; Vreeburg, EM | 1 |
Becker, ML; Franken, WP; Karapinar, F; Schalekamp, T; van der Hoeven, RT; Verzijl-Zeegers, R | 1 |
Lozano, R | 1 |
1 trial(s) available for omeprazole and acenocoumarol
Article | Year |
---|---|
No effect of short-term omeprazole intake on acenocoumarol pharmacokinetics and pharmacodynamics.
Topics: Acenocoumarol; Adult; Anticoagulants; Area Under Curve; Biological Availability; Double-Blind Method; Drug Interactions; Half-Life; Humans; Male; Metabolic Clearance Rate; Omeprazole; Prothrombin Time; Stereoisomerism | 1997 |
5 other study(ies) available for omeprazole and acenocoumarol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy.
Topics: Acenocoumarol; Administration, Oral; Aged; Anti-Ulcer Agents; Anticoagulants; Case-Control Studies; Drug Interactions; Female; Humans; Liver; Male; Omeprazole; Peptic Ulcer; Retrospective Studies | 1997 |
Possible drug-drug interaction between high-dose esomeprazole and phenprocoumon.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acenocoumarol; Aged; Aged, 80 and over; Anti-Ulcer Agents; Anticoagulants; Dose-Response Relationship, Drug; Drug Interactions; Esomeprazole; Female; Hospitalization; Hospitals, Teaching; Humans; International Normalized Ratio; Male; Omeprazole; Pantoprazole; Phenprocoumon | 2015 |
Drug-drug interactions between acenocoumarol and proton pump inhibitors in hospitalized patients: Overanticoagulation associated with intravenous omeprazole.
Topics: Acenocoumarol; Drug Interactions; Enzyme Inhibitors; Humans; Omeprazole; Pharmaceutical Preparations; Proton Pump Inhibitors | 2021 |